Rafa Laboratories LTD

$168M obligated·10 awards·1 agencies·2 NAICS

Federal Contracts

Showing award actions 1–14 of 14 funded award actions, most recent first.

Contracts with positive obligations: 10
Funded award actions shown: 14
Obligations shown: $168M
Awarding agencies: 1

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of August 10, 2026. Source: USAspending federal award records.

Date	Agency	PIID	NAICS	Description	Amount
Aug 10, 2026	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50125C00018	541714	THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA	$230K
Jul 29, 2026	Department of Health and Human ServicesASPR/ORM-SNS	75A50325C00020	325412	RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)	$12M
Sep 30, 2025	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50125C00018	541714	THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA	$12M
Sep 30, 2025	Department of Health and Human ServicesASPR/ORM-SNS	75A50325C00020	325412	RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)	$21M
Sep 22, 2025	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50123C00055	541714	THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPINE AUTOINJECTOR FOR PEDIATRIC USE USING AN IMPROVED VERSION OF RAFA LABORATORIES, LTD.S (RAFAS) FDA-APPROVED SI	$1.7M
Sep 19, 2023	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50123C00055	541714	THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPINE AUTOINJECTOR FOR PEDIATRIC USE USING AN IMPROVED VERSION OF RAFA LABORATORIES, LTD.S (RAFAS) FDA-APPROVED SI	$7.7M
Sep 21, 2021	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50121F33006	325412	RAFA DO 6	$23M
Sep 29, 2020	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50120F33005	325412	ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE	$7.8M
Sep 25, 2019	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119F33004	325412	TASK ORDER FOR ADDITIONAL PRODUCTS	$9.7M
Aug 8, 2019	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	75A50119F33004	325412	TASK ORDER FOR ADDITIONAL PRODUCTS	$6.2M
Mar 13, 2018	Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES	HHSD2002017925240003	325412	ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ	$32M
Jun 30, 2017	Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES	HHSD2002017925240002	325412	ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ	$28M
Jan 31, 2017	Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES	HHSD2002017925240001	325412	ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - TO1	$7.1M
Dec 22, 2016	Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES	HHSD200201792524I	325412	ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ	$10K

Get Alerted Before Rafa Laboratories LTD's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free